Feasibility study of portable technology for weight loss and HbA1c control in type 2 diabetes

• DOI: 10.1186/s12911-016-0331-2
• Publication Date: 2016-07-14T19:01:54Z
• Authors: Claire L. Bentley; Olubukola Otesile; Ruth Bacigalupo; Jackie Elliott; Hayley Noble; Mark S. Hawley; Elizabeth A. Will...; Peter Cudd
• Keywords: Adult; Glycated Hemoglobin; Male; Motivation; Health Policy; Feedback, Psychological; Health Informatics; Middle Aged; 16. Peace & justice; Mobile Applications; Telemedicine; 3. Good health; 03 medical and health sciences; 0302 clinical medicine; Diabetes Mellitus, Type 2; Patient Satisfaction; Weight Loss; Feasibility Studies; Humans; Female; Obesity; Exercise; Research Article

The study investigated the feasibility of conducting a future Randomised Controlled Trial (RCT) mobile health (mHealth) intervention for weight loss and HbA1c reduction in Type 2 Diabetes Mellitus (T2DM).The was small wearable mHealth device used over 12 weeks by overweight people with T2DM intent to lose reduce their level. A 4 week maintenance period using followed. records physical activity level information about food consumption, provides motivational feedback based on energy balance. Twenty-seven participants were randomised receive no intervention; alone; or plus weekly support. All received advice diet exercise at start study. Weight levels recorded baseline 6, 12, 16. Qualitative interviews conducted who explore experiences involvement including training received.Overall perceived be well-liked, acceptable, easy use participants. Some logistical changes required during study, shortening duration relaxation participant inclusion criteria. Descriptive statistics data showed promising trends both groups, although this should interpreted caution.A number methodological recommendations RCT emerged from current acceptable helping individuals weight. Devices similar features tested further larger studies which follow these recommendations.